NovaBridge Biosciences (NBP) Operating Margin (2020 - 2023)
NovaBridge Biosciences (NBP) reported Operating Margin of 3375.87% for Q3 2023, up 55.46% on a QoQ basis from 7578.62% in Q2 2023.
NovaBridge Biosciences (NBP) has 2 years of Operating Margin data on file, last reported at 3375.87% in Q3 2023.
- Quarterly Operating Margin changed N/A year-over-year to 3375.87% in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 4391386.42% (changed N/A YoY) and the FY2023 annual result came in at 1875.73%, up 154644.0% from the prior year.
- Operating Margin grew to 3375.87% in Q3 2023 per NBP's latest filing, from 7578.62% in the prior quarter.
- Across five years, Operating Margin topped out at 3375.87% in Q3 2023 and bottomed at 31714.02% in Q4 2020.
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -3,375.87% |
| Jun 30, 2023 | -7,578.62% |
| Dec 31, 2020 | -31,714.02% |